ESTA Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc., a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. Establishment Labs Holdings Inc. was founded in 2004 and is headquartered in Alajuela, Costa Rica.

$63.42  -1.08 (-1.67%)
As of 12/03/2021 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  British Virgin Islands
IPO date:  07/19/2018
Outstanding shares:  24,003,667
Average volume:  155,212
Market cap:   $1,548,236,522
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G31249108
ISIN:        VGG312491084
Sedol:      BYVR2D4
Valuation   (See tab for details)
PE ratio:   -46.58
PB ratio:   24.65
PS ratio:   13.08
Return on equity:   -52.94%
Net income %:   -27.54%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy